COPD is a common and complex disease for both inpatient and outpatient providers. GOLD guidelines provide diagnosis and treatment recommendations for COPD and were recently updated. Join host Geoff Wall as he breaks down the salient recommendations in the 2023 GOLD guidelines.

The GameChanger
A new severity scoring system for COPD exists – category E. Additionally, inhaled corticosteroids may play a larger role in the pharmacotherapy of COPD.

Show Segments
00:00 - Introductions
01:40 - Background on COPD
04:09 - The GameChanger: Severity Scoring Changes
08:23 - Connecting to Practice: Impact of Inhaler Technique
16:08 - Use of Inhaled Corticosteroids
23:23 - Closing Remarks


Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

• 2023 GOLD Report

Redeem your CPE or CME here

• CPE (Pharmacist) 
• CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

• Pharmacists: Get a membership
• Prescribers: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the new severity scoring system for COPD in the 2023 GOLD guidelines
2. Discuss appropriate use of inhaled corticosteroids in COPD patients

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-422-H04-P
Initial release date: 12/20/2022
Expiration date: 12/20/2023
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram